A study to assess empasiprubart in adults with multifocal motor neuropathy

Trial Identifier:	ARDA
Sponsor:	Argenx
Start Date:	March 2022
Study Completion Date:	June 2024
Condition:	Neurological & Brain - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.